Five Phase III Data Readouts To Look Out For In Q2

Crunch Time For Alexion, Aldeyra, Byondis, Novan

 
• By Kevin Grogan
  
Spotlight
Spotlight on Phase III data coming in the second quarter • Source: Alamy

More from Clinical Trials

More from R&D